The PDX ROS1-fusion tumor cell line, LUAD-0006, is resistant to all

Establishment and characterization of a cell line and patient

Marissa Mattar's research works Memorial Sloan Kettering Cancer

The PDX ROS1-fusion tumor cell line, LUAD-0006, is resistant to

A focal adhesion kinase-YAP signaling axis drives drug tolerant

Frontiers Lung cancer organoids: models for preclinical research

Frontiers Ferroptosis-Related Genes in Lung Adenocarcinoma

A highly multiplexed quantitative phosphosite assay for biology

The PDX ROS1-fusion tumor cell line, LUAD-0006, is resistant to

Diagnosis of Non-Small Cell Lung Cancer via Liquid Biopsy

Direct identification of ALK and ROS1 fusions in non-small cell lung